Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–2.
Article CAS PubMed PubMed Central Google Scholar
Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Gautier JF, Ravussin Y. A new symptom of COVID-19: loss of taste and smell. Obesity. 2020;28(5):848.
Article CAS PubMed Google Scholar
Delikhoon M, Guzman MI, Nabizadeh R, Norouzian BA. Modes of transmission of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and factors influencing on the airborne transmission: a review. Int J Environ Res Public Health. 2021;18(2):395.
Article CAS PubMed PubMed Central Google Scholar
Alimohammadi M, Abolli S, Ghordouei ME. Perceiving effect of environmental factors on prevalence of SARS-Cov-2 virus and using health strategies: a review. J Adv Environ Health Res. 2022;10(3):187–96.
Li XZ, Jin F, Zhang JG, Deng YF, Shu W, Qin JM, et al. Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis. Infect Dis Poverty. 2020;9(1):78.
Article CAS PubMed PubMed Central Google Scholar
Jin H, Wang H, Li X, Zheng W, Ye S, Zhang S, et al. Economic burden of COVID-19, China, January–March, 2020: a cost-of-illness study. Bull World Health Organ. 2021;99(2):112.
Bartsch SM, Ferguson MC, McKinnell JA, O'Shea KJ, Wedlock PT, Siegmund SS, et al. The potential health care costs and resource use associated with COVID-19 in the United States. Health Aff (Millwood). 2020;39(6):927–35.
Juranek S, Paetzold J, Winner H, Zoutman F. Labor market effects of COVID-19 in Sweden and its neighbors: evidence from novel administrative data. NHH Dept of Business and Management Science Discussion Paper. (2020/8); 2020.
Maltezou H, Giannouchos T, Pavli A, Tsonou P, Dedoukou X, Tseroni M, et al. Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis. J Hosp Infect. 2021;114:126–33.
Article CAS PubMed PubMed Central Google Scholar
Faramarzi A, Javan-Noughabi J, Tabatabaee SS, Najafpoor AA, Rezapour A. The lost productivity cost of absenteeism due to COVID-19 in health care workers in Iran: a case study in the hospitals of Mashhad University of Medical Sciences. BMC Health Serv Res. 2021;21(1):1169.
Article PubMed PubMed Central Google Scholar
Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L, et al. Economic burden of COVID-19: a systematic review. Clinicoecon Outcomes Res. 2022;14:293–307.
Article PubMed PubMed Central Google Scholar
Forsythe S, Cohen J, Neumann P, Bertozzi SM, Kinghorn A. The economic and public health imperatives around making potential coronavirus disease–2019 treatments available and affordable. Value Health. 2020;23(11):1427–31.
Article PubMed PubMed Central Google Scholar
Rodela TT, Tasnim S, Mazumder H, Faizah F, Sultana A, Hossain MM. Economic impacts of coronavirus disease (COVID-19) in developing countries; 2020.
Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group* t. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics. 2011;29:653–71.
Konnopka A, König H. Economic burden of anxiety disorders: a systematic review and meta-analysis. Pharmacoeconomics. 2020;38:25–37.
Jeck J, Jakobs F, Kron A, Franz J, Cornely OA, Kron F. A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital. Infection. 2022;50(1):191–201.
Article CAS PubMed Google Scholar
Kotwani P, Patwardhan V, Pandya A, Saha S, Patel GM, Jaiswal S, et al. Valuing out-of-pocket expenditure and health related quality of life of COVID-19 patients from Gujarat, India. J Commun Dis (E-ISSN: 2581-351X & P-ISSN: 0019-5138). 2021;53(1):104–9.
Tsai Y, Vogt TM, Zhou F. Patient characteristics and costs associated with COVID-19–related medical care among Medicare fee-for-service beneficiaries. Ann Intern Med. 2021;174(8):1101–9.
Weiner JP, Bandeian S, Hatef E, Lans D, Liu A, Lemke KW. In-person and telehealth ambulatory contacts and costs in a large US insured cohort before and during the COVID-19 pandemic. JAMA Netw Open. 2021;4(3):e212618-e.
Di Fusco M, Shea KM, Lin J, Nguyen JL, Angulo FJ, Benigno M, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308–17.
Edoka I, Fraser H, Jamieson L, Meyer-Rath G, Mdewa W. Inpatient care costs of COVID-19 in South Africa’s public healthcare system. Int J Health Policy Manag. 2022;11(8):1354.
Tabuñar SM, Dominado TM. Hospitalization expenditure of COVID-19 patients at the university of the Philippines-Philippine general hospital (UP-PGH) with PhilHealth coverage. Acta Med Philipp. 2021;55(2)
Zhao J, Yao Y, Lai S, Zhou X. Clinical immunity and medical cost of COVID-19 patients under grey relational mathematical model. Results Phys. 2021;22:103829.
Article PubMed PubMed Central Google Scholar
Ghaffari Darab M, Keshavarz K, Sadeghi E, Shahmohamadi J, Kavosi Z. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran. BMC Health Serv Res. 2021;21(1):1–7.
Barasa E, Kairu A, Maritim M, Were V, Akech S, Mwangangi M. Examining unit costs for COVID-19 case management in Kenya. BMJ Glob Health. 2021;6(4):e004159.
Seon J-Y, Jeon W-H, Bae S-C, Eun B-L, Choung J-T, Oh I-H. Characteristics in pediatric patients with coronavirus disease 2019 in Korea. J Korean Med Sci. 2021;36(20):e148.
Article CAS PubMed PubMed Central Google Scholar
Banke-Thomas A, Makwe CC, Balogun M, Afolabi BB, Alex-Nwangwu TA, Ameh CA. Utilization cost of maternity services for childbirth among pregnant women with coronavirus disease 2019 in Nigeria’s epicenter. Int J Gynaecol Obstet. 2021;152(2):242–8.
Article CAS PubMed Google Scholar
Li X-Z, Jin F, Zhang J-G, Deng Y-F, Shu W, Qin J-M, et al. Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis. Infect Dis Poverty. 2020;9(03):31–8.
Kirigia JM, Muthuri RNDK. The fiscal value of human lives lost from coronavirus disease (COVID-19) in China. BMC Res Notes. 2020;13:1–5.
Lee JK, Kwak BO, Choi JH, Choi EH, Kim J-H, Kim DH. Financial burden of hospitalization of children with coronavirus disease 2019 under the national health insurance service in Korea. J Korean Med Sci. 2020;35(24):e224.
Article PubMed PubMed Central Google Scholar
Khan AA, AlRuthia Y, Balkhi B, Alghadeer SM, Temsah M-H, Althunayyan SM, et al. Survival and estimation of direct medical costs of hospitalized COVID-19 patients in the Kingdom of Saudi Arabia. Int J Environ Res Public Health. 2020;17(20):7458.
Article CAS PubMed PubMed Central Google Scholar
Mas Romero M, Avendaño Céspedes A, Tabernero Sahuquillo MT, Cortés Zamora EB, Gómez Ballesteros C, Sánchez-Flor Alfaro V, et al. COVID-19 outbreak in long-term care facilities from Spain. Many lessons to learn. PLoS One. 2020;15(10):e0241030.
Article CAS PubMed PubMed Central Google Scholar
Nguyen NT, Sullivan B, Sagebin F, Hohmann SF, Amin A, Nahmias J. Analysis of COVID-19 patients with acute respiratory distress syndrome managed with extracorporeal membrane oxygenation at US academic centers. Ann Surg. 2021;274(1):40.
Viscusi WK. Economic lessons for COVID-19 pandemic policies. South Econ J. 2021;87(4):1064–89.
Article PubMed PubMed Central Google Scholar
Santos HLPC, Maciel FBM, Santos Junior GM, Martins PC, Prado NMBL. Public expenditure on hospitalizations for COVID-19 treatment in 2020, in Brazil. Rev Saude Publica. 2021;55:52.
Article PubMed PubMed Central Google Scholar
Zhao J, Jin H, Li X, Jia J, Zhang C, Zhao H, et al. Disease burden attributable to the first wave of COVID-19 in China and the effect of timing on the cost-effectiveness of movement restriction policies. Value Health. 2021;24(5):615–24.
Article PubMed PubMed Central Google Scholar
John D, Narassima M, Menon J, Rajesh JG, Banerjee A. Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis. BMJ Open. 2021;11(8):e049619.
Nurchis MC, Pascucci D, Sapienza M, Villani L, D’Ambrosio F, Castrini F, et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17(12):4233.
Comments (0)